Sydney Jennings

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 vaccinations, cases, and deaths in the US and on cases and deaths worldwide.

Dapagliflozin is the first SGLT-2 inhibitor to receive FDA approval for the treatment of CKD, regardless of diabetes status.

CDC Director Rochelle Walensky, MD MPH, was a featured presenter at the recent ACP Internal Medicine Meeting 2021: Virtual Experience, where she spoke about lessons learned during COVID-19.

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.

Primary care practices are keeping pace a year into the pandemic but face rising challenges—from mental exhaustion to lack of vaccine supplies, according to a national primary care survey.

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.

The large survey found that 9 out of 10 patients believe their pain levels and quality of life have worsened under the CDC's 2016 opioid prescribing guideline.

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.

New findings suggest that patients with asthma and type 2 diabetes who use GLP-1 RAs for diabetes treatment intensification have fewer asthma exacerbations compared to other diabetes drugs.

US confirmed cases of COVID-19 have surpassed 32 million. Plus more data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.

The findings suggest that the mouth and its saliva play an important, and perhaps underappreciated, role in SARS-CoV-2 infection and transmission.

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.

Primary care physicians face unique challenges when managing patients with obesity, but one obesity specialist aims to show clinicians how to meet them, even if it's in small ways.

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.

A new study found that mobile-based ECG screening for AF could improve health outcomes among American Indian adults who have historically endured greater health disparities.

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.

Patients with asthma or COPD living in areas with high levels of air pollution are at an increased risk of hospitalization if they contract COVID-19, suggests a new pilot study.

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.

Results of a new study show that young adults who exercise up to 5 hours per week have a reduced risk of developing hypertension later in life.

The uptake among primary care physicians of new migraine drugs has been hindered by 2 significant obstacles, a headache specialist explained to Patient Care Online.

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.

In a new recommendation statement, the US Preventive Services Task Force concluded that current evidence is insufficient to support broad screening for vitamin D deficiency in adults.

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.

Fatigue was among the most common symptoms that health care workers in Sweden reported 8 months after mild COVID-19 infection, according to a new research letter.

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.

A single injection of casirivimab and imdevimab reduced the risk for symptomatic SARS-CoV-2 infection by 81% among household contacts of infected persons, according to new phase 3 study results.

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.